METAvivor funds research that specifically addresses the mechanistic understanding, diagnosis, and/or treatment of metastatic breast cancer. All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.
Applications for the 2018 award cycle are no longer being accepted. Please sign up for email updates below and watch for the 2019 cycle to open.
METAvivor offers two awards focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients:
METAvivor Research Award (MRA) is a 2-year, $200,000 grant for established investigators. A total of $100,000 is awarded for year 1. Second year funding is contingent upon year 1 progress report approval by METAvivor.
METAvivor Early Career Investigator Award (ECIA) is a 1-year, $50,000 award available to early career applicants (investigators within 6 years of starting their first non-tenured position or within 10 years of receiving their professional degree).
For future details on submission instructions and deadlines, sign up for email notifications regarding upcoming grants.
Thank you for your interest and participation.